Arbutus Biopharma Corporation

ABUS ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
144 Mar 31, 2025
10-K Mar 27, 2025 10-K
8-K Mar 27, 2025 FORM 8-K
144 Mar 24, 2025
4 Mar 20, 2025 FORM 4
4 Mar 20, 2025 FORM 4
4 Mar 20, 2025 FORM 4
144 Mar 19, 2025
144 Mar 13, 2025
144 Mar 7, 2025
3 Mar 6, 2025 FORM 3
3 Mar 6, 2025 FORM 3
3 Mar 6, 2025 FORM 3
3 Mar 6, 2025 FORM 3
3 Mar 6, 2025 FORM 3
8-K Mar 3, 2025 FORM 8-K
SCHEDULE 13D/A Feb 25, 2025
8-K Feb 25, 2025 FORM 8-K
SCHEDULE 13D/A Feb 21, 2025
4 Feb 19, 2025 FORM 4
4 Feb 19, 2025 FORM 4
4 Feb 19, 2025 FORM 4
4 Feb 19, 2025 FORM 4
SCHEDULE 13D/A Feb 18, 2025
4 Feb 5, 2025 FORM 4
← Newer Page 4 of 43 · 1054 filings Older →